DXCM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
DXCM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-06-10), DexCom's current share price is $115.79. DexCom's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was $0.42. DexCom's Cyclically Adjusted Price-to-FCF for today is 275.69.
The historical rank and industry rank for DexCom's Cyclically Adjusted Price-to-FCF or its related term are showing as below:
During the past years, DexCom's highest Cyclically Adjusted Price-to-FCF was 7281.25. The lowest was 217.69. And the median was 628.38.
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.
DexCom's adjusted free cash flow per share data for the three months ended in Mar. 2024 was $0.365. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $0.42 for the trailing ten years ended in Mar. 2024.
The historical data trend for DexCom's Cyclically Adjusted Price-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DexCom Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Cyclically Adjusted Price-to-FCF | Get a 7-Day Free Trial | 439.74 | 431.26 | 264.93 | 335.88 | 333.85 |
For the Medical Devices subindustry, DexCom's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, DexCom's Cyclically Adjusted Price-to-FCF distribution charts can be found below:
* The bar in red indicates where DexCom's Cyclically Adjusted Price-to-FCF falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.
DexCom's Cyclically Adjusted Price-to-FCF for today is calculated as
Cyclically Adjusted Price-to-FCF | = | Share Price | / | Cyclically Adjusted FCF per Share |
= | 115.79 | / | 0.42 | |
= | 275.69 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DexCom's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:
For example, DexCom's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:
Adj_FreeCashFlowPerShare | = | Free Cash Flow per Share | / | CPI of Mar. 2024 (Change) | * | Current CPI (Mar. 2024) |
= | 0.365 | / | 131.7762 | * | 131.7762 | |
= | 0.365 |
Current CPI (Mar. 2024) = 131.7762.
DexCom Quarterly Data
Free Cash Flow per Share | CPI | Adj_FreeCashFlowPerShare | |
201406 | 0.007 | 100.560 | 0.009 |
201409 | 0.025 | 100.428 | 0.033 |
201412 | 0.012 | 99.070 | 0.016 |
201503 | -0.015 | 99.621 | -0.020 |
201506 | 0.032 | 100.684 | 0.042 |
201509 | 0.033 | 100.392 | 0.043 |
201512 | -0.001 | 99.792 | -0.001 |
201603 | -0.036 | 100.470 | -0.047 |
201606 | 0.029 | 101.688 | 0.038 |
201609 | 0.021 | 101.861 | 0.027 |
201612 | -0.013 | 101.863 | -0.017 |
201703 | -0.066 | 102.862 | -0.085 |
201706 | 0.007 | 103.349 | 0.009 |
201709 | 0.065 | 104.136 | 0.082 |
201712 | 0.068 | 104.011 | 0.086 |
201803 | -0.069 | 105.290 | -0.086 |
201806 | 0.087 | 106.317 | 0.108 |
201809 | 0.091 | 106.507 | 0.113 |
201812 | 0.045 | 105.998 | 0.056 |
201903 | -0.076 | 107.251 | -0.093 |
201906 | 0.048 | 108.070 | 0.059 |
201909 | 0.121 | 108.329 | 0.147 |
201912 | 0.269 | 108.420 | 0.327 |
202003 | -0.083 | 108.902 | -0.100 |
202006 | 0.247 | 108.767 | 0.299 |
202009 | 0.252 | 109.815 | 0.302 |
202012 | 0.281 | 109.897 | 0.337 |
202103 | -0.172 | 111.754 | -0.203 |
202106 | -0.093 | 114.631 | -0.107 |
202109 | 0.323 | 115.734 | 0.368 |
202112 | 0.059 | 117.630 | 0.066 |
202203 | -0.071 | 121.301 | -0.077 |
202206 | 0.193 | 125.017 | 0.203 |
202209 | 0.434 | 125.227 | 0.457 |
202212 | 0.162 | 125.222 | 0.170 |
202303 | 0.193 | 127.348 | 0.200 |
202306 | 0.304 | 128.729 | 0.311 |
202309 | 0.513 | 129.860 | 0.521 |
202312 | 0.194 | 129.419 | 0.198 |
202403 | 0.365 | 131.776 | 0.365 |
Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.
Thank you for viewing the detailed overview of DexCom's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Sadie Stern | officer: Chief Human Resources Officer | 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121 |
Steven R Altman | director | |
Kevin R Sayer | director | |
Jereme M Sylvain | officer: SVP, Finance & CAO | 6340 SEQUENCE DRIVE, SAN DIEGO X1 92121 |
Jacob Steven Leach | officer: SVP, Research & Development | 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121 |
Nicholas Augustinos | director | 754 GRAND VIEW AVENUE, SAN FRANCISCO CA 94114 |
Micheal Jon Brown | officer: EVP, Chief Legal Officer | 6340 SEQUENCE DR, SAN DIEGO CA 92121 |
Steven Robert Pacelli | officer: Vice President Legal Affairs | 5555 OBERLIN DRIVE, SAN DIEGO CA 92121 |
Girish Naganathan | officer: EVP Chief Technology Officer | C/O DEXCOM, INC., 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121 |
Barry J. Regan | officer: EVP Operations | 1023 CHERRY ROAD, MEMPHIS TN 38117 |
Bridgette P Heller | director | TECH DATA CORPORATION, 5350 TECH DATA DRIVE, CLEARWATER FL 33760 |
Matthew Vincent Dolan | officer: * | 6340 SEQUENCE DR, SAN DIEGO CA 92121 |
Rimma Driscoll | director | C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054 |
Shelly Ramasamy Selvaraj | officer: SVP Information Technology | 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121 |
Paul R Flynn | officer: EVP, Global Revenue | 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121 |
From GuruFocus
By Business Wire • 01-23-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024